Oslo, Norway, 31 July 2019 – Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, announces that the Company is invited to present at the Solebury Trout European Biotech Investor Day 2019 in NYC.
Date: 1 August 2019
Time: 10:30 AM EDT
Presenter: Øystein Soug (CEO)
The presentation will be available to download at www.targovax.com after the event.